The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index; 16 of the 42 sources its claims cite were checked for support.
Comparisons of the effects of different flaxseed products consumption on lipid profiles, inflammatory cytokines and anthropometric indices in patients with dyslipidemia related diseases: systematic review and a dose-response meta-analysis of randomized controlled trials
Open accessAbstract
This systematic review and dose-response meta-analysis of randomized controlled trials evaluated effects of different flaxseed products on lipid profiles and inflammatory parameters in patients with dyslipidemia related diseases.
Overview
CoChat Summary
## TL;DR
This systematic review and dose-response meta-analysis of 31 RCTs (1,698 participants) found that flaxseed products had beneficial effects on several lipid, inflammatory, and some anthropometric outcomes in patients with dyslipidemia-related diseases, but effects differed by product type. Whole flaxseed and lignans mainly improved lipid measures, while flaxseed oil mainly reduced inflammatory markers.
## Key findings
- 31 RCTs involving 1,698 participants were included; 875 were assigned to flaxseed interventions and 823 to controls.
- Overall, flaxseed-containing products significantly reduced total cholesterol (TC) by WMD −8.73 mg/dL, LDL-C by WMD −6.92 mg/dL, triglycerides (TG) by WMD −12.31 mg/dL, apo B by WMD −4.70 mg/dL, and IL-6 by WMD −0.23 pg/mL.
- Whole flaxseed significantly reduced TC (−11.85 mg/dL), LDL-C (−10.51 mg/dL in the abstract; −10.52 mg/mL in the dose subgroup text), TG (−19.77 mg/dL), apo B (−5.73 mg/dL in the abstract; −5.50 mg/dL in the detailed results), TC/HDL-C (−0.10), and weight (−0.40 kg).
- Lignans significantly reduced TC (−17.86 mg/dL), LDL-C (−15.47 mg/dL), and TC/HDL-C (−0.45), while flaxseed oil significantly reduced IL-6 (−0.35 pg/mL) and hs-CRP (−1.54 mg/L).
- No significant effects were seen for HDL-C, apo B/apo A ratio, CRP, TNF-α, BMI, WC overall, or WHR overall.
## Methods
- Systematic review and dose-response meta-analysis of randomized controlled trials in adults with dyslipidemia-related diseases, following PRISMA.
- Searches were run in PubMed, Embase, Cochrane Library, Scopus, and Web of Science from inception to January 2020; only human studies in English were included.
- Pooled weighted mean differences were calculated with fixed- or random-effects models; heterogeneity was assessed with Q and I², with meta-regression, subgroup analyses, sensitivity analyses, and Egger’s test used to explore moderators, robustness, and publication bias.
## Limitations
- The paper states that many SDs of net change were estimated using correlation-based methods rather than exact values.
- It states that between-study heterogeneity could not be fully removed because of differing patient backgrounds, control groups, and uneven study quality.
- It states that some studies may have been missed because grey literature was not searched and non-English studies were excluded.
- The text also makes evident that several outcomes had high heterogeneity and some publication bias signals (for example, TC and LDL-C), which limits confidence in pooled estimates.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
9 Valid · 2 Not valid · 13 Not checked · 111 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“A recent register study of more than 1 million US veterans found a U-shaped relationship between HDL-C and total mortality with 50 mg/dL (1.25 mmol/L) as the nadir associated with the lowest mortality [76].”
§ Comparisons of the effects of different flaxseed products consumption on lipid profiles, inflammatory cytokines and anthropometric indices in patients with dyslipidemia related diseases: systematic review and a dose–response meta-analysis of randomized controlled trials > Discussion
What the sources say
- Partly supportedcites [76] Bowe B, Xie Y, Xian H, Balasubramanian S, Zayed MA, Al-Aly Z. High density lipoprotein cholesterol and the risk of all-cause mortality among U.S. veterans. Clin J Am Soc Nephrol. 2016;11:1784–93. sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) describes a cohort of 1,764,986 U.S. veterans and a U-shaped association between HDL-C and all-cause mortality. The Results section (page unavailable) places the lowest risk in the middle HDL-C deciles, but does not identify 50 mg/dL as the nadir; 50 mg/dL is the boundary of a higher-HDL-C category. (LLM, conf=0.89)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Previous meta-analysis assessed the effects of flaxseed and flaxseed-derived products (flaxseed oil or lignans) on inflammatory cytokines, did not reach consistent conclusions [15, 80, 81].”
§ Comparisons of the effects of different flaxseed products consumption on lipid profiles, inflammatory cytokines and anthropometric indices in patients with dyslipidemia related diseases: systematic review and a dose–response meta-analysis of randomized controlled trials > Discussion
What the sources say
- Partly supportedcites [15] Rahimlou M, Jahromi NB, Hasanyani N, Ahmadi AR. Effects of flaxseed interventions on circulating inflammatory biomarkers: a systematic review and meta-analysis of randomized controlled trials. Adv Nutr. 2019;10:1108–19. sourceExperimental — accuracy not yet measured
The Abstract (page unavailable) identifies this paper as a meta-analysis of flaxseed and its derivatives and reports differing results across inflammatory biomarkers. It says clinical studies had contradictory findings, but does not establish that previous meta-analyses reached inconsistent conclusions; the Discussion (page unavailable) calls this the first comprehensive meta-analysis on the topic. (LLM, conf=0.82)
- Not checked — no full text of the sourcecites [80] Askarpour M, Karimi M, Hadi A, Ghaedi E, Symonds ME, Miraghajani M, Javadian P. Effect of flaxseed supplementation on markers of inflammation and endothelial function: a systematic review and meta-analysis. Cytokine. 2020;126:154922. source
- Partly supportedcites [81] Ren G-Y, Chen C-Y, Chen G-C, Chen W-G, Pan A, Pan C-W, Zhang Y-H, Qin L-Q, Chen L-H. Effect of flaxseed intervention on inflammatory marker C-reactive protein: a systematic review and meta-analysis of randomized controlled trials. Nutrients. 2016;8:136. sourceExperimental — accuracy not yet measured
The Abstract identifies this paper as a meta-analysis of flaxseed and its derivatives, but its outcome is CRP, not inflammatory cytokines generally. The Introduction says the underlying clinical trials had inconsistent findings; it does not say that previous meta-analyses reached inconsistent conclusions. Page numbers are unavailable in our copy. (LLM, conf=0.86)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Secondly, several studies also have provided evidence that the vascular effects of HDL are variable and hardly correlate with HDL-C concentrations in the plasma.”
§ Comparisons of the effects of different flaxseed products consumption on lipid profiles, inflammatory cytokines and anthropometric indices in patients with dyslipidemia related diseases: systematic review and a dose–response meta-analysis of randomized controlled trials > Discussion
What the sources say
- Supportedcites [78] März W, Kleber ME, Scharnagl H, Speer T, Zewinger S, Ritsch A, Parhofer KG, von Eckardstein A, Landmesser U, Laufs U. HDL cholesterol: reappraisal of its clinical relevance. Clin Res Cardiol. 2017;106:663–75. source
The HDL dysfunction section states the claim directly: studies found that HDL’s vascular effects vary and hardly correlate with plasma HDL-C concentrations. The same section adds that HDL’s properties are poorly reflected by its cholesterol content. (LLM, conf=0.95)
- Partly supportedcites [79] Verwer BJ, Scheffer PG, Vermue RP, Pouwels PJ, Diamant M, Tushuizen ME. NAFLD is related to post-prandial triglyceride-enrichment of HDL particles in association with endothelial and HDL dysfunction. Liver Int. 2020;40:2439–44. sourceExperimental — accuracy not yet measured
The Background (page not provided) reports that HDL’s anti-atherogenic properties can change with triglyceride enrichment, potentially affecting endothelial protection. The Results (page not provided) associate endothelial function with HDL triglyceride enrichment. Neither passage establishes that HDL’s vascular effects hardly correlate with plasma HDL-C concentrations. (LLM, conf=0.83)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“lowering-effect on IL-6 (− 0.35 pg/ml, P = 0.033)”
§ Comparisons of the effects of different flaxseed products consumption on lipid profiles, inflammatory cytokines and anthropometric indices in patients with dyslipidemia related diseases: systematic review and a dose–response meta-analysis of randomized controlled trials > Abstract > Results Thirty-one RCTs involving 1,698 participants were included. The present meta-analysis revealed that flaxseed consumption had an overall beneficial effect on serum TC, LDL-C, TG, apo B and IL-6 in patients with dyslipidemia related diseases, but not on apo A, HDL-C, hs-CRP, CRP and anthropometric indices. However, different flaxseed products showed obviously different effects. Whole flaxseed supplementation significantly reduced TC (− 11.85 mg/dl, 95% CI − 20.12 to − 3.57, P = 0.005), LDL-C (− 10.51 mg/dl, 95% CI − 14.96 to − 6.06, P < 0.001), TG (− 19.77 mg/dl, 95% CI − 33.61 to − 5.94, P = 0.005), apolipoprotein B (− 5.73 mg/dl, 95% CI − 7.53 to − 3.93, P < 0.001), TC/HDL-C (− 0.10, 95% CI − 0.19 to − 0.003, P = 0.044) and weight (− 0.40 kg, 95% CI − 0.76 to − 0.05, P = 0.027); Lignans supplementation significantly reduced TC (− 17.86 mg/dl, P = 0.004), LDL-C (− 15.47 mg/dl, P < 0.001) and TC/HDL-C (− 0.45, P = 0.04). Although flaxseed oil supplementation had no such lowering-effect on lipid, meta-analysis revealed its lowering-effect on IL-6 (− 0.35 pg/ml, P = 0.033) and hs-CRP (− 1.54 mg/l, P = 0.004). Subgroup analysis revealed that whole flaxseed decreased TC, LDL-C and TG levels irrespective of country and the intervention time prescribed, but was more pronounced when the dose of whole flaxseed was ≤ 30 g/day (TC: WMD − 13.61 mg/mL; LDL-C: WMD − 10.52 mg/mL; TG: WMD − 23.52 mg/mL), rather not a dose > 30 g/day. Moreover, a linear relationship between dose of whole flaxseed and absolute changes in C-reactive protein (P = 0.036) and a nonlinear relationship between with IL-6 (P < 0.001) were detected.
plainstates a causen = 1,698 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“serum LDL-C (I2 = 95.7%)”
§ Comparisons of the effects of different flaxseed products consumption on lipid profiles, inflammatory cytokines and anthropometric indices in patients with dyslipidemia related diseases: systematic review and a dose–response meta-analysis of randomized controlled trials > Meta-analysis results > Flaxseed supplementation on lipid profiles in patients with dyslipidemia-related diseases
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
87 more claims
Create a free account to see all 135 claims and every source verdict.
- It may state two separate claims as one. 25
- Probably not a substantial claim. 19
- The quote only partly states this claim. 4
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Comparisons of the effects of different flaxseed products consumption on lipid profiles, inflammatory cytokines and anthropometric indices in patients with dyslipidemia related diseases: systematic review and a dose–response meta-analysis of randomized controlled trials > Abstract > Results
“Whole flaxseed supplementation significantly reduced TC (− 11.85 mg/dl, 95% CI − 20.12 to − 3.57, P = 0.005), LDL-C (− 10.51 mg/dl, 95% CI − 14.96 to − 6.06, P < 0.001), TG (− 19.77 mg/dl, 95% CI − 33.61 to − 5.94, P = 0.005), apolipoprotein B (− 5.73 mg/dl, 95% CI − 7.53 to − 3.93, P < 0.001),”
§ Comparisons of the effects of different flaxseed products consumption on lipid profiles, inflammatory cytokines and anthropometric indices in patients with dyslipidemia related diseases: systematic review and a dose–response meta-analysis of randomized controlled trials > Meta-analysis results > Flaxseed supplementation on lipid profiles in patients with dyslipidemia-related diseases
“whole flaxseed supplementation has significant effects on apolipoproteins (Apo A: − 4.14 mg/dL, 95% CI − 4.92, − 3.36; I2 = 26.2%; Apo B: − 5.50 mg/dL, 95% CI − 8.80, − 2.20; I2 = 58.1%;)”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Comparisons of the effects of different flaxseed products consumption on lipid profiles, inflammatory cytokines and anthropometric indices in patients with dyslipidemia related diseases: systematic review and a dose–response meta-analysis of randomized controlled trials > Meta-analysis results > Flaxseed supplementation on lipid profiles in patients with dyslipidemia-related diseases
“rather than HDL-C concentrations (LDL-C: intercept = 0.28, P = 0.423).”
§ Comparisons of the effects of different flaxseed products consumption on lipid profiles, inflammatory cytokines and anthropometric indices in patients with dyslipidemia related diseases: systematic review and a dose–response meta-analysis of randomized controlled trials > Meta-analysis results > Flaxseed supplementation on lipid profiles in patients with dyslipidemia-related diseases
“Egger’s linear regression revealed a potential publication bias in the meta-analysis of flaxseed’s effects on plasma LDL-C concentrations (LDL-C: intercept = − 1.97, P < 0.01), rather than HDL-C concentrations”
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
“Cassani RS, Fassini PG, Silvah JH, Lima CM, Marchini JS. Impact of weight loss diet associated with flaxseed on inflammatory markers in men with cardiovascular risk factors: a clinical study. Nutr J. 2015;14:5.”
Cited work 10.1186/1475-2891-14-5 · retracted 2016-04-21 · notice 10.1186/s12937-016-0165-x · this paper published 2021-10-11
Citations
Cites
1 retracted
Cassani, R. S. L., Fassini, P. G., Silvah, J. H., de Lima, C. M. M., & Marchini, J. S. (2015) · Nutrition Journal · doi:10.1186/1475-2891-14-5 · Cited by 77
RetractedThe Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2010) · International Journal of Surgery · doi:10.1016/j.ijsu.2010.02.007 · Cited by 12,156
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
Trumbo, P., Schlicker, S., Yates, A. A., & Poos, M. (2002) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(02)90346-9 · Cited by 5,993
USDA National Nutrient Database for Standard reference
(2018) · Cited by 751
Al-Lahham, S. H., Peppelenbosch, M. P., Roelofsen, H., Vonk, R. J., & Venema, K. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.07.007 · Cited by 614
Flaxseed as a functional food source
Oomah, B. D. (2001) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.898 · Cited by 584
Flaxseed: A Potential Source of Food, Feed and Fiber
Singh, K. K., Mridula, D., Rehal, J., & Barnwal, P. (2011) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408390903537241 · Cited by 523
Cited by
The Role of Flaxseed in Improving Human Health
Nowak, W., & Jeziorek, M. (2023) · Healthcare · doi:10.3390/healthcare11030395 · Cited by 118
Takić, M. M., Pokimica, B., Petrović-Oggiano, G., & Popović, T. (2022) · Molecules · doi:10.3390/molecules27144471 · Cited by 103
“, 2021 [77] Dyslipidemic Molecules 2022, 27, x FOR PEER REVIEW 9 of 24”
BackgroundFeei, Z., Fu, C., & Lee, Y. Y. (2025) · Foods · doi:10.3390/foods14050821 · Cited by 58
“In addition, lignans have been shown to improve cholesterol regulation, reduce inflammation, and provide antimicrobial and cancer protection [32,34].”
Villarreal-Renteria, A. I., Herrera-Echauri, D. D., Rodríguez-Rocha, N. P., Zúñiga, L. Y., Muñóz-Valle, J. F., García‐Arellano, S., Bernal-Orozco, M. F., & Ojeda, G. M. (2022) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2022.102852 · Cited by 39
Fats and oils – a scoping review for Nordic Nutrition Recommendations 2023
Rosqvist, F., & Niinistö, S. (2024) · Food & Nutrition Research · doi:10.29219/fnr.v68.10487 · Cited by 37
“Finally, a SR and meta-analysis from 2021, based on nine RCTs, found no differential effect of flaxseed oil on total cholesterol, LDL-cholesterol, HDL-cholesterol or triglycerides compared to other oils (sunflower oil, safflower oil, corn oil) in patients with dys-lipidemia-related diseases (40).”
BackgroundMethod
Metadata
- Authors
- Yang, C., Xia, H., Wan, M., Lu, Y., Xu, D., Yang, X., Yang, L., & Sun, G.
- Affiliations
- Southeast University (CN)
- Corresponding author
- Sun, Guiju
- Venue
- Nutrition & Metabolism
- Published
- 2021-10-11
- Volume
- 18
- Issue
- 1
- Pages
- 91-91
- ISSN
- 1743-7075 (ISSN-L)
- PMC
- PMC8504108
- OpenAlex
- W3207254176
- Cited by
- 40
- References
- 95
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 8 · 2023: 3 · 2022: 8
- FWCI
- 0.63
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nutrition & Metabolism (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (81872618, 82073551)
- Postgraduate Research & Practice Innovation Program of Jiangsu Province (KYCX19_0121)
- Scientific Research Foundation of Graduate School of Southeast University (YBPY1944)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Nursing › Nutrition and Dietetics › Food composition and properties
- Keywords
- flaxseed, linseed oil, lignans, dyslipidemia, lipid profile, LDL cholesterol, triglycerides, apolipoprotein B, inflammatory cytokines, interleukin-6, C-reactive protein, anthropometric indices, weight, dose-response relationship, functional foods, dietary supplementation, linolenic acid, dietary fiber, TC/HDL-C ratio, HDL cholesterol
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comparisons of the effects of different flaxseed products consumption on lipid profiles, inflammatory cytokines and anthropometric indices in patients with dyslipidemia related diseases: systematic review and a dose-response meta-analysis of randomized controlled trials. https://app.cochat.ai/papers/10.1186/s12986-021-00619-3
- The paper
- Yang, C., Xia, H., Wan, M., Lu, Y., Xu, D., Yang, X., Yang, L., & Sun, G. (2021). Comparisons of the effects of different flaxseed products consumption on lipid profiles, inflammatory cytokines and anthropometric indices in patients with dyslipidemia related diseases: systematic review and a dose-response meta-analysis of randomized controlled trials. Nutrition & Metabolism. https://doi.org/10.1186/s12986-021-00619-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.